Compare Enveric Biosciences Inc (ENVB) vs Synchrony Financial (SYF) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Enveric Biosciences Inc vs Synchrony Financial — how do they compare? Enveric Biosciences Inc trades at $1.36 (market cap $5.32M), while Synchrony Financial trades at $74.33 (market cap $24.90B). The key difference: Synchrony Financial is far larger — about 4680.5× Enveric Biosciences Inc's market cap, and Synchrony Financial pays a 1.62% dividend while Enveric Biosciences Inc pays none. Which is the better fit depends on your goals.
| ENVB | SYF | |
|---|---|---|
Market Cap | $5.32M | $24.90B |
Sector | Health | Financials |
52-Week High | $17.40 | $88.47 |
52-Week Low | $1.28 | $63.78 |
Enterprise Value | $408.82K | — |
Dividend Yield | — | 1.62% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Synchrony Financial (SYF) trades at $74.11, up 0.58% with strong fundamentals including a 7.66 P/E ratio and 24.06% net income margin. The stock shows bearish technical signals despite three consecutive earnings beats, with Q2 2026 results expected on July 21. Recent corporate developments include executive leadership changes and new digital partnerships, while analyst consensus remains strongly bullish with a $86.38 price target.
SYF presents value opportunity with attractive valuation metrics and consistent earnings performance, though technical indicators suggest near-term pressure. Key risks include credit quality sensitivity to economic conditions and competitive pressures in consumer lending. The 16% upside to consensus target and zero sell ratings support the bullish analyst sentiment despite current technical weakness.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Enveric Biosciences Inc
Enveric Biosciences is a biotechnology company focused on developing next-generation psychedelic-inspired therapies for mental health and neuropsychiatric disorders.
Read more on ENVB →About Synchrony Financial
Synchrony Financial is a premier consumer financial services company and the largest provider of private-label credit cards in the United States. Spun off from GE Capital in 2014, it operates through a unique B2B2C model, embedding its financing products within the ecosystems of major partners like Amazon, Lowe’s, and PayPal. Synchrony leverages deep data analytics and a diverse multi-platform strategy—spanning retail, health, and auto—to drive customer loyalty and provide specialized credit solutions at the point of sale.
Read more on SYF →
